Ovarian High Grade Serous Adenocarcinoma

Ovarian High Grade Serous Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

43 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 29
Recruiting: 13
Ph III recruiting: 1
Growth YoY: —
Industry share: 10%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (6)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03606486	Lavage of the Uterine Cavity for Diagnosis of Ovarian Cancer	terminated	N/A	52	University of WashingtonOTHER	1	Jan 17, 2024	clinicaltrials

Data updated 23 days agoSource updated Jan 17, 2024source: clinicaltrials